Solarvest Announces Natural Sciences and Engineering Research Council of Canada (NSERC) Funding Approvals

SOLARVEST BIOENERGY INC. (TSX VENTURE:SVS) ("Solarvest"), announces that it has
been successful at receiving approval for two NSERC projects. After determining
a company's eligibility as it pertains to research, technology and
commercialization abilities an approved company may apply to support a specific
research objective(s) in conjunction with an eligible Canadian College or
University. The projects often support a post graduate student researching in a
NSERC supported field, who is funded by NSERC to work with the company to
further their R&D objectives. Solarvest has applied for and received approval
for the two projects outlined below.


The first NSERC Industrial Postgraduate Scholarships Program (IPS) project
"Expression of recombinant proteins in Chlamydomonas reinhardtii (algae) using a
unique fusion system" is in partnership with Dr. Illimar Altosaar's laboratory
at the University of Ottawa. C. reinhardtii has demonstrated protein expression
at commercially significant levels with the benefit of having the cellular
machinery to properly fold and assemble human proteins and antibodies that
reproduce natural forms. This results in highly effective and valuable proteins
that make excellent candidates for active biologics and vaccines. The project
will study a method of expression with the objective of developing a process
that will enable the efficient and cost effective purification of recombinant
therapeutic proteins. 


The second approved Engage Program project "Molecular characterization of the
Solarvest H2 (hydrogen) producing algal strain for the development of targets
for strain and process improvement" is in partnership with Dr. Patrick C.
Hallenbeck's laboratory at the University of Montreal. The project is focused on
further defining specific operational conditions that will enhance hydrogen
production in the Solarvest proprietary algal strain Chlamydomonas reinhardtii
Cyc6nac2. 49 and to identify key molecules that are involved in regulating
increased hydrogen production. Efficient hydrogen production is sought due to
its value as a totally clean fuel. Hydrogen can be burned or used in a fuel cell
and releases heat energy and water as its only byproduct. 


About Solarvest BioEnergy:

Solarvest BioEnergy Inc. is an algae technology company whose algal-based
production platform provides it with an extremely flexible system capable of
being adapted to produce clean energy in the form of hydrogen and health
products such as Omega oils in an economic and environmentally sensitive manner.



The TSX Venture Exchange has neither approved nor disapproved the contents of
this news release. Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.


The statements made in this news release may contain forward-looking statements
that may involve a number of risks and uncertainties. Actual events or results
could differ materially from Solarvest's expectations and projections.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Solarvest BioEnergy Inc.
Gerri Greenham
Chief Executive Officer
416 420 0947
ggreenham@solarvest.ca
www.solarvest.ca

Solarvest BioEnergy (TSXV:SVS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024